Hidehito Horinouchi: Impact of Durvalumab on corticosteroid therapy for pneumonitis after chemoradiotherapy

Hidehito Horinouchi, Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital, shared on X:

“Impact of Durvalumab on the Duration and Complexity of Corticosteroid Therapy for Pneumonitis After Chemoradiotherapy.

Saori Murata, Hidehito Horinouchi, Clinical Lung Cancer.

Representation of duration and complexity of tapering patterns.”

Source: Hidehito Horinouchi/X

Impact of Durvalumab on the Duration and Complexity of Corticosteroid Therapy for Pneumonitis After Chemoradiotherapy.

Authors: Saori Murata, Hidehito Horinouchi, Momoko Morishita, Sawako Kaku, Yuki Shinno, Yusuke Okuma, Tatsuya Yoshida, Yasushi Goto, Noboru Yamamoto, Tairo Kashihara, Kae Okuma, Masahiko Kusumoto, and Yuichiro Ohe.